Cases 31 - 40 of 238
GIC PRIVATE LIMITED v. CELGENE CORPORATION et al
as 2:2021cv16767
Plaintiff:
GIC PRIVATE LIMITED
Defendant:
CELGENE CORPORATION, SCOTT A. SMITH, TERRIE CURRAN and others
Molina Healthcare, Inc. v. Celgene Corporation et al
as 3:2021cv05483
Plaintiff:
Molina Healthcare, Inc.
Defendant:
Celgene Corporation and Bristol-Myers Squibb Company
Cause Of Action: 28 U.S.C. § 1441
AMERICAN CENTURY MUTUAL FUNDS, INC., on behalf of its series Select Fund, Ultra Fund, Growth Fund (solely as successor-in-interest to All Cap Growth Fund, a series of American Century Mutual Funds, In et al v. CELGENE CORPORATION et al
as 2:2021cv13785
Plaintiff:
AMERICAN CENTURY MUTUAL FUNDS, INC., on behalf of its series Select Fund, Ultra Fund, Growth Fund (solely as successor-in-interest to All Cap Growth Fund, a series of American Century Mutual Funds, In, AMERICAN CENTURY VARIABLE PORTFOLIOS, INC., on behalf of its series VP Balanced Fund, VP Disciplined Core Value Fund, VP Ultra Fund, and VP Large Company Value Fund, AMERICAN CENTURY CAPITAL PORTFOLIOS, INC., on behalf of its series Value Fund (solely as successor-in-interest to Capital Value Fund, a series of American Century Mutual Funds, Inc.), NT Focused Large and others
Defendant:
CELGENE CORPORATION, SCOTT A. SMITH, TERRIE CURRAN and others
DFA INVESTMENT DIMENSIONS GROUP INC. et al v. CELGENE CORPORATION et al
as 2:2021cv13739
Plaintiff:
DFA INVESTMENT DIMENSIONS GROUP INC., U.S. CORE EQUITY 1 PORTFOLIO, U.S. CORE EQUITY 2 PORTFOLIO and others
Defendant:
CELGENE CORPORATION, SCOTT A. SMITH, TERRIE CURRAN and others
CELGENE CORPORATION v. TORRENT PHARMACEUTICALS LTD. et al
as 2:2021cv12927
Plaintiff:
CELGENE CORPORATION
Defendant:
TORRENT PHARMA INC. and TORRENT PHARMACEUTICALS LTD.
Cause Of Action: 35 U.S.C. § 271
CIGNA CORPORATION v. CELGENE CORPORATION et al
as 2:2021cv11686
Plaintiff:
CIGNA CORPORATION
Defendant:
BRISTOL-MYERS SQUIBB COMPANY and CELGENE CORPORATION
Cause Of Action: 15 U.S.C. § 1
AMERICAN CENTURY MUTUAL FUNDS, INC., on behalf of its series Select Fund, Ultra Fund, Growth Fund (solely as successor-in-interest to All Cap Growth Fund, a series of American Century Mutual Funds, In et al v. CELGENE CORPORATION et al
as 2:2021cv13784
Plaintiff:
AMERICAN CENTURY MUTUAL FUNDS, INC., on behalf of its series Select Fund, Ultra Fund, Growth Fund (solely as successor-in-interest to All Cap Growth Fund, a series of American Century Mutual Funds, In, AMERICAN CENTURY VARIABLE PORTFOLIOS, INC., on behalf of its series VP Balanced Fund, VP Disciplined Core Value Fund, VP Ultra Fund, and VP Large Company Value Fund, AMERICAN CENTURY CAPITAL PORTFOLIOS, INC., on behalf of its series Value Fund (solely as successor-in-interest to Capital Value Fund, a series of American Century Mutual Funds, Inc.), NT Focused Large and others
Defendant:
CELGENE CORPORATION, SCOTT A. SMITH, TERRIE CURRAN and others
CELGENE CORPORATION v. BIOCON PHARMA LIMITED et al
as 2:2021cv11261
Plaintiff:
CELGENE CORPORATION
Defendant:
BIOCON LIMITED, BIOCON PHARMA, INC. and BIOCON PHARMA LIMITED
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HIKMA PHARMACEUTICALS USA, INC.
as 2:2021cv10398
Plaintiff:
CELGENE CORPORATION
Defendant:
HIKMA PHARMACEUTICALS USA, INC.
Cause Of Action: 35 U.S.C. § 271
BLUE CROSS AND BLUE SHIELD ASSOCIATION v. CELGENE CORPORATION et al
as 2:2021cv10187
Plaintiff:
BLUE CROSS AND BLUE SHIELD ASSOCIATION and THE FEDERAL EMPLOYEE PROGRAM, A FEDERAL EMPLOYEE HEALTH BENEFITS ACT PLAN
Defendant:
BRISTOL-MYERS SQUIBB COMPANY and CELGENE CORPORATION
Cause Of Action: 15 U.S.C. § 25
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
